FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37844529> ?p ?o ?g. }

• Q37844529 description "article científic" @default.
• Q37844529 description "article scientifique" @default.
• Q37844529 description "articolo scientifico" @default.
• Q37844529 description "artigo científico" @default.
• Q37844529 description "artículu científicu espublizáu en 2011" @default.
• Q37844529 description "bilimsel makale" @default.
• Q37844529 description "scientific article published on March 2011" @default.
• Q37844529 description "vedecký článok" @default.
• Q37844529 description "vetenskaplig artikel" @default.
• Q37844529 description "videnskabelig artikel" @default.
• Q37844529 description "vědecký článek" @default.
• Q37844529 description "wetenschappelijk artikel" @default.
• Q37844529 description "wissenschaftlicher Artikel" @default.
• Q37844529 description "наукова стаття, опублікована в березні 2011" @default.
• Q37844529 description "научни чланак" @default.
• Q37844529 description "مقالة علمية نشرت في مارس 2011" @default.
• Q37844529 name "A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer" @default.
• Q37844529 name "A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer" @default.
• Q37844529 name "A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer" @default.
• Q37844529 type Item @default.
• Q37844529 label "A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer" @default.
• Q37844529 label "A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer" @default.
• Q37844529 label "A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer" @default.
• Q37844529 prefLabel "A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer" @default.
• Q37844529 prefLabel "A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer" @default.
• Q37844529 prefLabel "A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer" @default.
• Q37844529 P1433 Q37844529-D6D626B4-2735-4E57-B946-29C819DAEA6B @default.
• Q37844529 P1476 Q37844529-B83E81EF-F93F-4569-ADBD-A82C9F9C2E8F @default.
• Q37844529 P2093 Q37844529-3CBD68C0-2D3C-4385-83CD-0D0791A6FF15 @default.
• Q37844529 P2093 Q37844529-4620BA2B-BA7D-4DEC-802C-195FED4D65F5 @default.
• Q37844529 P2860 Q37844529-043EEE7D-1EDD-4367-BBFE-A12A7667BF47 @default.
• Q37844529 P2860 Q37844529-05844019-D133-496A-A150-4EF694B283C5 @default.
• Q37844529 P2860 Q37844529-0A17ACED-E067-4626-9A55-F2D114F18D58 @default.
• Q37844529 P2860 Q37844529-1CFBEB90-71A0-4CC4-BEA1-D64C65027945 @default.
• Q37844529 P2860 Q37844529-1D0FD930-A0FD-48DF-9796-36D3ACD08338 @default.
• Q37844529 P2860 Q37844529-35257742-8D66-4BF0-9B8E-8058163854AD @default.
• Q37844529 P2860 Q37844529-3B92D4C7-7D4C-4480-9F38-3A8968422DA5 @default.
• Q37844529 P2860 Q37844529-41187CF1-DDD9-48BD-8FAA-3D3DB3684076 @default.
• Q37844529 P2860 Q37844529-43E57661-902E-494D-A567-0BD804BB20DE @default.
• Q37844529 P2860 Q37844529-48619C3A-B6DD-4493-9674-9900C22534A1 @default.
• Q37844529 P2860 Q37844529-53931835-C2A7-420F-90D8-A233BC062EB2 @default.
• Q37844529 P2860 Q37844529-55D96D46-49F2-49B2-A272-FE94D496FEC8 @default.
• Q37844529 P2860 Q37844529-5A7F6C71-515F-4B4A-A046-A6B238D2674E @default.
• Q37844529 P2860 Q37844529-5D231BC3-0B18-49F8-BF7F-CF1B79258B7B @default.
• Q37844529 P2860 Q37844529-68CFF969-9BE7-4FE4-A40B-0AC2D9F01374 @default.
• Q37844529 P2860 Q37844529-68E82180-26FD-4F7B-B3B2-B723FB8C14EA @default.
• Q37844529 P2860 Q37844529-6A2FF853-721B-42B1-9360-A9B131BDF7EC @default.
• Q37844529 P2860 Q37844529-6A7E6BA7-5727-4847-8484-1266727C42CA @default.
• Q37844529 P2860 Q37844529-6CF53EAA-3DD5-4570-AF6C-E344933A3F00 @default.
• Q37844529 P2860 Q37844529-716F1732-3FA4-4357-8D06-503D6CE7A82A @default.
• Q37844529 P2860 Q37844529-7520A2C0-CCBC-448E-914E-67EFCF6F26A2 @default.
• Q37844529 P2860 Q37844529-77C88FDE-330B-441A-B6B3-51BE36148DD5 @default.
• Q37844529 P2860 Q37844529-7971A372-115A-424E-B053-15044AA03EB3 @default.
• Q37844529 P2860 Q37844529-7A80AC3E-9BEB-43B6-86C3-CAB3FBD44344 @default.
• Q37844529 P2860 Q37844529-7C0B8344-29FE-4569-8C01-F429456417EA @default.
• Q37844529 P2860 Q37844529-7CF523F4-FCB4-4C1E-8CDE-836A4F0672AD @default.
• Q37844529 P2860 Q37844529-865EEC9B-0808-45FA-9268-27B9BE121100 @default.
• Q37844529 P2860 Q37844529-87F79BF1-1D4A-46BA-8FE0-0F0BC311F79D @default.
• Q37844529 P2860 Q37844529-88F3EEB6-D5D9-457E-9DC2-9B84B0CB2812 @default.
• Q37844529 P2860 Q37844529-89AB15C6-9517-4586-B7DC-CC0BFD307781 @default.
• Q37844529 P2860 Q37844529-8D50C367-3A37-45AB-A1E2-3D1B5D81212E @default.
• Q37844529 P2860 Q37844529-9099E1F3-C7C0-4275-83F5-408B3C33FE5B @default.
• Q37844529 P2860 Q37844529-935D1D7B-4486-4BDD-AA67-AFAC530B5B86 @default.
• Q37844529 P2860 Q37844529-953ECD83-A6DF-4475-80E3-7091BAB5F713 @default.
• Q37844529 P2860 Q37844529-9CD1E3FA-D044-46CB-9393-A8CCF99C04A2 @default.
• Q37844529 P2860 Q37844529-A917B9B9-76EC-4E6C-9CB4-AAA66DC89F5D @default.
• Q37844529 P2860 Q37844529-A933F29F-6402-4187-91EB-FFC9B1AE36AB @default.
• Q37844529 P2860 Q37844529-AD410BE9-F5F8-48D0-89A5-F7C3A51C6587 @default.
• Q37844529 P2860 Q37844529-C1D7C5A7-C28E-41FF-8FC0-E0ABAE6C7390 @default.
• Q37844529 P2860 Q37844529-C6D23A95-0084-4E6B-910F-B66AD079E0AE @default.
• Q37844529 P2860 Q37844529-DCEF1F48-C7D1-4EDA-80C5-7E7D16EADEC4 @default.
• Q37844529 P2860 Q37844529-E0712C47-5948-4C7F-8EC1-CD7B3AD49DAE @default.
• Q37844529 P2860 Q37844529-E09B7B89-8C57-48A7-A2B7-83742ECE735F @default.
• Q37844529 P2860 Q37844529-E2EBD7CB-20B0-46DA-83AC-7990CD7B88EF @default.
• Q37844529 P2860 Q37844529-E44D8A57-F206-4C9F-8DF4-FAC9BAE34D9D @default.
• Q37844529 P2860 Q37844529-E8F858F7-A3BE-4A86-AB83-4FD6BADB0564 @default.
• Q37844529 P2860 Q37844529-EBF57ECB-6A81-43E1-A1EA-62FC890F3622 @default.
• Q37844529 P2860 Q37844529-ED242A21-A224-4ACA-BE8B-3FD058FB10E9 @default.
• Q37844529 P2860 Q37844529-ED52B963-E76B-47FB-8641-ABE93B8A8C62 @default.
• Q37844529 P2860 Q37844529-EFD030BC-F573-4072-911F-D68AC86A4466 @default.
• Q37844529 P2860 Q37844529-F8F81143-21C2-4C1B-B9D2-4DE654546E53 @default.
• Q37844529 P2888 Q37844529-28FB67C9-AF5C-457F-8106-B2AF8FF37951 @default.
• Q37844529 P304 Q37844529-FFD3755F-68E8-435C-8F9A-7B293E12C8E2 @default.
• Q37844529 P31 Q37844529-74b65432-71e7-4e38-99ab-ebffd31b3d34 @default.
• Q37844529 P31 Q37844529-C4C730E0-FDB9-4547-A274-E33299A38386 @default.
• Q37844529 P356 Q37844529-87B6431A-3F30-478E-AC14-21AF00C0FD4A @default.
• Q37844529 P433 Q37844529-D0650A3C-4434-44E1-AF27-2D668FAED880 @default.
• Q37844529 P478 Q37844529-50F11A97-8532-4947-AF92-141755F8FA40 @default.
• Q37844529 P577 Q37844529-AEEDDF44-17F0-4DFF-BEB7-89379C95D9DD @default.
• Q37844529 P6179 Q37844529-93BB802D-6925-4759-8D54-739AAEEAF3F9 @default.
• Q37844529 P698 Q37844529-3B490104-5252-478B-B50F-3BA4C1C0EE0C @default.
• Q37844529 P921 Q37844529-1E2325A9-8EC3-4E38-824B-98CD90CC1257 @default.
• Q37844529 P921 Q37844529-46C9BA30-36D6-4DEE-9134-52A7A3F365CD @default.
• Q37844529 P356 11586540-000000000-00000 @default.
• Q37844529 P698 21332242 @default.
• Q37844529 P1433 Q15724462 @default.
• Q37844529 P1476 "A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer" @default.
• Q37844529 P2093 "Giannis Mountzios" @default.
• Q37844529 P2093 "Kostas N Syrigos" @default.
• Q37844529 P2860 Q27824812 @default.

• next